These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 372851

  • 21. [Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
    Araszkiewicz W.
    Gruzlica; 1969 Mar; 37(3):223-34. PubMed ID: 5814946
    [No Abstract] [Full Text] [Related]

  • 22. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 23. Veterinary tuberculosis vaccine development.
    Griffin JF.
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S223-8. PubMed ID: 10875788
    [Abstract] [Full Text] [Related]

  • 24. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y, Mitarai S, Otomo K, Seki M, Sato A, Yano I, Koyama A, Hattori T.
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [Abstract] [Full Text] [Related]

  • 25. [Pneumoconiosis and mycobacterial infection].
    Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
    [Abstract] [Full Text] [Related]

  • 26. [Indications for chemoprophylaxis in tuberculosis in BCG-vaccinated children].
    Brickman HF, Beaudry PH.
    Union Med Can; 1979 Nov; 108(11):1342-6. PubMed ID: 549240
    [No Abstract] [Full Text] [Related]

  • 27. [Update on the BGC vaccine. Indications for use in Europe and in developing countries].
    Guerin N, Levy-Bruhl D.
    Med Trop (Mars); 1996 Nov; 56(2):173-6. PubMed ID: 8926881
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The history of tuberculosis.
    Daniel TM.
    Respir Med; 2006 Nov; 100(11):1862-70. PubMed ID: 16949809
    [Abstract] [Full Text] [Related]

  • 31. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D.
    Arch Intern Med; 1996 Apr 22; 156(8):889-94. PubMed ID: 8774208
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Relations between vaccination and chemoprophylaxis with INH].
    Lucchesi M, Spina G.
    Lotta Tuberc; 1965 Apr 22; 35(11):1049-54. PubMed ID: 5223589
    [No Abstract] [Full Text] [Related]

  • 35. [Respective roles of BCG and isoniazid chemoprophylaxis in the prevention of tuberculosis in underdeveloped and developing countries].
    Omodei Zorini A.
    Ann Sanita Pubblica; 1965 Apr 22; 26(4):779-86. PubMed ID: 5881717
    [No Abstract] [Full Text] [Related]

  • 36. BCG vaccination to prevent tuberculosis in health care workers: a decision analysis.
    Marcus AM, Rose DN, Sacks HS, Schechter CB.
    Prev Med; 1997 Apr 22; 26(2):201-7. PubMed ID: 9085388
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW, Wards BJ, Buddle BM, Collins DM.
    Tuberculosis (Edinb); 2005 Apr 22; 85(1-2):73-9. PubMed ID: 15687030
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.